|
2024
|
Invention
|
Prodrugs of itaconate and methyl itaconate.
Prodrugs of itaconic acid and 1- and 4-methyl itacon... |
|
|
Invention
|
Neutral sphingomyelinase inhibitors. Compounds and their use in treating a condition, disease, or... |
|
|
Invention
|
Targeted universal delivery system of don and other drugs. Conjugates comprising one or more ther... |
|
2022
|
Invention
|
Carbohydrate derivatives and kits for cell surface labeling. Provided herein are carbohydrate der... |
|
|
Invention
|
Carbohydrate derivatives and kits for cell surface labeling. transin vitroin vivoin vivo and thei... |
|
|
Invention
|
Prodrugs of prostate specific membrane antigen (psma) inhibitor. Methods and compounds are disclo... |
|
|
Invention
|
3'3' cyclic dinucleotides containing isonucleotidic units. The present disclosure relates to 3'3'... |
|
2021
|
Invention
|
Prodrugs of 6-mercaptopurine. Prodrugs of 6-mercaptopurine (6-MP) and methods of their use for tr... |
|
|
Invention
|
Decitabine analogs for immunological and oncological therapy.
Novel N4-substituted decitabine an... |
|
|
Invention
|
Decitabine analogs for immunological and oncological therapy. N44in vitroin vivoin vivo therapeut... |
|
|
Invention
|
Prodrugs of hydroxamate-based gcpii inhibitors. Prodrugs of hydroxamate-based GCPII inhibitors an... |
|
|
Invention
|
3′3′ cyclic dinucleotides with an alkenylene.
The present disclosure describes 3′3′ cyclic phosp... |
|
|
Invention
|
3'3' cyclic dinucleotides with an alkenylene. The present disclosure relates to 3'3' cyclic phosp... |
|
|
Invention
|
Bile acid-gcpii inhibitor conjugates to treat inflammatory diseases. GCPII inhibitors comprising ... |
|
2020
|
Invention
|
Prodrugs of itaconate and methyl itaconate. Prodrugs of itaconic acid and 1- and 4-methyl itaconi... |
|
2019
|
Invention
|
Mebendazole prodrugs with enhanced solubility and oral bioavailability. Prodrugs of mebendazole a... |
|
2018
|
Invention
|
Prodrugs of glutamine analogs. Prodrugs of glutamine analogs, such as prodrugs of acivicin, are d... |
|
|
Invention
|
Small molecule inhibitors of neutral sphingomyelinase 2 (nsmase2) for the treatment of neurodegen... |
|
2016
|
Invention
|
Prodrugs of glutamine analogs. Prodrugs of glutamine analogs, such as prodrugs of aza-serine, and... |
|
2014
|
Invention
|
Compounds for use in inhibiting hiv capsid assembly. The present invention relates to a compound ... |
|
|
Invention
|
Compounds for use in inhibiting hiv capsid assembly. The present invention relates a compound or ... |
|
2010
|
Invention
|
Novel antimicrobial peptides. This invention involves two novel peptides of the formulas (1) H-Gl... |
|
2009
|
Invention
|
Cytostatic 7-deazapurine nucleosides. The invention provides compounds of formula (I), wherein R1... |
|
|
Invention
|
Novel cytostatic 7-deazapurine nucleosides. The invention provides compounds of formula (I), wher... |
